Aileron Therapeutics, Inc. (ALRN)

NASDAQ: ALRN · IEX Real-Time Price · USD
0.400
-0.010 (-2.44%)
At close: May 26, 2022 4:00 PM
0.395
-0.005 (-1.250%)
After-hours:May 26, 2022 7:33 PM EDT

Balance Sheet (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2021202020192018201720162015
Cash & Equivalents
3.637.645.3410.6611.9520.83.83
Short-Term Investments
42.336.7612.9710.0638.8900
Cash & Cash Equivalents
45.9614.418.320.7250.8420.83.83
Cash Growth
219.20%-21.34%-11.67%-59.24%144.39%443.02%-
Other Current Assets
2.221.931.251.0610.270.2
Total Current Assets
48.1816.3319.5521.7851.8421.074.03
Property, Plant & Equipment
0.280.026.367.290.150.110.35
Long-Term Investments
000.570.57000
Other Long-Term Assets
0.02000.680.690.841.56
Total Long-Term Assets
0.30.026.928.540.850.951.91
Total Assets
48.4816.3426.4730.3152.6922.025.94
Accounts Payable
1.211.61.451.731.61.970.64
Current Debt
0.090.170.450000
Other Current Liabilities
3.212.23.943.643.292.11.91
Total Current Liabilities
4.513.965.845.374.894.072.55
Long-Term Debt
0.070.224.595.34000
Other Long-Term Liabilities
0000-0.010.03
Total Long-Term Liabilities
0.070.224.595.3400.010.03
Total Liabilities
4.584.1810.4310.714.894.082.58
Total Debt
0.160.395.035.34000
Debt Growth
-58.14%-92.31%-5.80%----
Common Stock
289.37231.46214.18188.1184.782.541.9
Retained Earnings
-245.46-219.29-198.14-168.49-136.95-114.34-96.22
Comprehensive Income
-0.01-00.01-0.01-0.0300
Shareholders' Equity
43.912.1616.0519.647.8-111.81-94.32
Total Liabilities and Equity
48.4816.3426.4730.3152.69-107.72-91.74
Net Cash / Debt
45.814.0113.2715.3850.8420.83.83
Net Cash / Debt Growth
226.86%5.58%-13.70%-69.75%144.39%443.02%-
Net Cash Per Share
0.520.400.541.046.8348.419.56
Working Capital
43.6712.3713.7116.4146.95171.48
Book Value Per Share
0.490.350.651.336.42-260.20-235.38
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).